A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments.

Baker, Emma H; Gnjidic, Danijela; Kirkpatrick, Carl M J; Pirmohamed, Munir; Wright, Daniel F B; Zecharia, Anna Y

Baker, Emma H; Gnjidic, Danijela; Kirkpatrick, Carl M J; Pirmohamed, Munir; Wright, Daniel F B; Zecharia, Anna Y.

Baker EH; St George's, University of London, London, UK.
Gnjidic D; British Pharmacological Society, London, UK.
Kirkpatrick CMJ; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Pirmohamed M; Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.
Wright DFB; Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.
Zecharia AY; Centre for Medicine Use and Safety, Monash University, Parkville, Australia.

Br J Clin Pharmacol ; 87(3): 707-711, 2021 03.

Article in English | MEDLINE | ID: covidwho-591613

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Pharmacovigilance; Antiviral Agents/adverse effects; Drug Evaluation, Preclinical; Humans; Immunologic Factors/administration & dosage; Immunologic Factors/therapeutic use; Pharmacology, Clinical; Randomized Controlled Trials as Topic; SARS-CoV-2/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pharmacovigilance / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Topics: Traditional medicine Limits: Humans Language: English Journal: Br J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Bcp.14416

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google